Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Escudier

Showing results (1-10 of 362) with videos related to

Pageof 37
Sort By:
Clinical Advances in Hematology & Oncology : H&O|August 8, 2007
Anti-VEGF therapy for renal cell carcinomaBernard Escudier
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2007
[Clinical results of Nexavar for the treatment of kidney cancer]Bernard Escudier
Expert Review of Anticancer Therapy|June 29, 2011
Sorafenib for the management of advanced renal cell carcinomaBernard Escudier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinomaBernard Escudier
The New England Journal of Medicine|February 20, 2019
Combination Therapy as First-Line Treatment in Metastatic Renal-Cell CarcinomaBernard Escudier
Cancer|February 3, 2011
Progression-free survival as a surrogate marker of overall survival: Is it the good question?Bernard Escudier
Lancet (London, England)|February 23, 2010
Chemo-immunotherapy in RCC: the end of a storyBernard Escudier
Drugs|June 6, 2007
Advanced renal cell carcinoma: current and emerging management strategiesBernard Escudier
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Does a reasonable treatment approach beyond second-line exist?Bernard Escudier
Expert Review of Anticancer Therapy|March 11, 2010
Sunitinib for the management of advanced renal cell carcinomaBernard Escudier
Pageof 37

Showing results (1-10 of 362) with videos related to

Sort By:
Pageof 37
Clinical Advances in Hematology & Oncology : H&O|August 8, 2007
Anti-VEGF therapy for renal cell carcinomaBernard Escudier
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2007
[Clinical results of Nexavar for the treatment of kidney cancer]Bernard Escudier
Expert Review of Anticancer Therapy|June 29, 2011
Sorafenib for the management of advanced renal cell carcinomaBernard Escudier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinomaBernard Escudier
The New England Journal of Medicine|February 20, 2019
Combination Therapy as First-Line Treatment in Metastatic Renal-Cell CarcinomaBernard Escudier
Cancer|February 3, 2011
Progression-free survival as a surrogate marker of overall survival: Is it the good question?Bernard Escudier
Lancet (London, England)|February 23, 2010
Chemo-immunotherapy in RCC: the end of a storyBernard Escudier
Drugs|June 6, 2007
Advanced renal cell carcinoma: current and emerging management strategiesBernard Escudier
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Does a reasonable treatment approach beyond second-line exist?Bernard Escudier
Expert Review of Anticancer Therapy|March 11, 2010
Sunitinib for the management of advanced renal cell carcinomaBernard Escudier
Pageof 37